Patrick Mauro Investment Advisor’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.49M Sell
186,365
-225,663
-55% -$5.9M 2.26% 16
2026
Q1
$11.6M Sell
412,028
-67,573
-14% -$1.8M 5.82% 5
2025
Q4
$11.9M Buy
479,601
+3,971
+0.8% +$100K 6.24% 3
2025
Q3
$12.1M Buy
475,630
+18,514
+4% +$457K 6.36% 4
2025
Q2
$10.7M Buy
457,116
+69,509
+18% +$1.62M 6.06% 4
2025
Q1
$9.82M Buy
387,607
+65,440
+20% +$1.71M 5.37% 5
2024
Q4
$8.55M Buy
322,167
+14,764
+5% +$400K 4.88% 6
2024
Q3
$8.9M Buy
307,403
+18,766
+7% +$547K 4.69% 6
2024
Q2
$8.08M Buy
288,637
+10,028
+4% +$276K 4.69% 6
2024
Q1
$7.73M Buy
278,609
+27,405
+11% +$760K 4.4% 7
2023
Q4
$7.23M Buy
251,204
+59,703
+31% +$1.8M 4.31% 7
2023
Q3
$6.35M Buy
191,501
+33,740
+21% +$1.19M 4.12% 9
2023
Q2
$5.79M Buy
157,761
+31,483
+25% +$1.23M 3.57% 12
2023
Q1
$5.15M Buy
126,278
+8,100
+7% +$350K 3.21% 12
2022
Q4
$6.06M Sell
118,178
-148
-0.1% -$7.1K 3.92% 10
2022
Q3
$5.18M Buy
+118,326
New +$5.75M 3.73% 10

Other funds holding PFE

Patrick Mauro Investment Advisor's PFE Position: Q2 2026 in Review

Patrick Mauro Investment Advisor reduced its Pfizer (PFE) stake by 55% in Q2 2026, selling an estimated $5.9M and leaving 186,365 shares worth $4.49M. The position accounts for 2.26% of the portfolio, ranked #16.

Patrick Mauro Investment Advisor first reported a position in PFE in Q3 2022 and has held it in 16 quarters since. The position peaked at $12.1M in Q3 2025. 2,814 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Patrick Mauro Investment Advisor held 186,365 shares of Pfizer worth $4.49M as of Q2 2026.
  • Patrick Mauro Investment Advisor sold 225,663 Pfizer shares in Q2 2026, an estimated $5.9M.
  • Pfizer made up 2.26% of Patrick Mauro Investment Advisor's portfolio in Q2 2026, its #16 holding.
  • Patrick Mauro Investment Advisor first reported a position in Pfizer in Q3 2022 and has held it in 16 quarters since.
  • Patrick Mauro Investment Advisor's Pfizer position peaked at $12.1M in Q3 2025.
  • 2,814 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Patrick Mauro Investment Advisor's 13F filing for Q2 2026, filed 10 Aug 2026.